Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NDUFS7 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RFNG - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DNASE1L1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EIF2B1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GATB - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GRN - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KCNA2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
APBA3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PIGT - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SPON1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RBMY1J - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
APOBEC3C - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ATP6V0D1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TAGLN2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TCF25 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MRPS12 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ATRN - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RPL10A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DLL3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ARHGAP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on